shot-button
Ganesh Chaturthi Ganesh Chaturthi
Home > News > World News > Article > Pfizer kids shot may not be available until November

Pfizer kids’ shot may not be available until November

Updated on: 30 September,2021 07:08 AM IST  |  Washington
Agencies |

The company has provided health regulators with data from recent study of its vaccine in children 5 to 11 years

Pfizer kids’ shot may not be available until November

An emergency medical technician, gives a second dose of the Pfizer-BioNTech COVID-19 vaccine to Aaron Delgado, 16, in Los Angeles on August 23. Pic/AFP

Pfizer has submitted research to the U.S Food and Drug Administration on the effectiveness of its Covid-19 vaccine in children but the shots may not be available until November.


The company said Tuesday it provided health regulators with data from a recent study of its vaccine in children 5 to 11 years old. Officials had said previously they would file an application with the FDA to authorize use in the coming weeks.


Once the company files its application, US regulators and public health officials will review the evidence and consult with their advisory committees in public meetings to determine if the shots are safe and effective enough to recommend use.


That process may mean the shots may not be available until closer to Thanksgiving, according to a person familiar with the process but not authorized to discuss it publicly. But it is possible that, depending on how quickly the FDA acts, the shots could become available earlier in November, the person said.

The drugmaker and its partner, Germany’s BioNTech, say they expect to request emergency use authorization of their vaccine in children ages 5 to 11 ‘in the coming weeks.’ The companies also plan to submit data to the European Medicines Agency and other regulators.

The two-shot Pfizer vaccine is currently available for those 12 and older. An estimated 100 million people in the US have been fully vaccinated with it, according to the Centres for Disease Control and Prevention.    

YouTube shuts channels of RT

YouTube says it has shut two German channels of Russian state broadcaster RT in a move centering on alleged coronavirus misinformation, a decision that drew threats of retaliation from Russia on Wednesday. YouTube, which is owned by Google, said RT’s German branch had received a ‘strike’ for uploading material that violated YouTube’s standards on Covid-19 misinformation, and as a consequence was suspended from uploading new videos to its channel.

Seven symptoms jointly predict Covid-19 

A set of seven symptoms, considered together, can be used to maximise detection of Covid-19 in the community, according to a study. The research, published on Wednesday in the journal PLOS Medicine, found loss or change of smell, loss or change of taste, fever, new persistent cough, chills, appetite loss, and muscle aches are the jointly predictive symptoms.

Positive housecats killed in China

A city in northern China has killed three housecats after they tested positive for Covid-19, according to a local media report. The authorities in Harbin said the action was taken because there was no available treatment for animals with the disease and they would have endangered their owner and other residents of the apartment complex in which they lived, Beijing News online said. The owner tested positive on September 21 and went into isolation. A community worker dropped in and gave the cats coronavirus tests, which twice came positive.

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliabilitsy and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!

Register for FREE
to continue reading !

This is not a paywall.
However, your registration helps us understand your preferences better and enables us to provide insightful and credible journalism for all our readers.

Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK